Butyrate metabolism in human colon carcinoma cells: Implications concerning its growth-inhibitory effect

Journal of Cellular Physiology

Volumn 218, Issue 1, 2009, Pages 58-65

  Andriamihaja, Mireille ^a   Chaumontet, Catherine ^a   Tome, Daniel ^a,b   Blachier, Francois ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b AGROPARISTECH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETYL COENZYME A; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; BUTYRIC ACID; CARBON 14; GLUCOSE; GLUTAMINE; MALIC ACID; ADENINE NUCLEOTIDE; BUTYRIC ACID DERIVATIVE; GROWTH INHIBITOR; HISTONE; MALIC ACID DERIVATIVE; NUCLEAR PROTEIN;

ACETYLATION; AEROBIC METABOLISM; ARTICLE; CARCINOMA CELL; CELL GROWTH; COLON CARCINOMA; CONTROLLED STUDY; FATTY ACID METABOLISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATION; PRIORITY JOURNAL; RADIOACTIVITY; ADENOCARCINOMA; BACTERIUM; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECT; LARGE INTESTINE; LIPID METABOLISM; METABOLISM; MICROBIOLOGY; OXIDATION REDUCTION REACTION; PATHOLOGY; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS);

ACETIC ACID; ADENINE NUCLEOTIDES; ADENOCARCINOMA; BACTERIA; BUTYRATES; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GLUTAMINE; GROWTH INHIBITORS; HISTONES; HUMANS; INTESTINE, LARGE; LIPID METABOLISM; MALATES; NUCLEAR PROTEINS; OXIDATION-REDUCTION;

EID: 58149145317     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21556     Document Type: Article

References (44)

1. Archer SY, Meng S, Shei A, Hodin RA. 1998. p2l WAFI is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95:6791-6796.
2. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Dasety V, Meng S, Hodin RA. 2004. The histone deacetylase inhibitor butyrate downregulates cyclin Bl gene expression via p2l/WAF-l-dependent mechanism in human colon cancer cells. Am J Physiol 289:G696-G703.
3. Ardawi MSM, Newsholme EA. 1985. Fuel utilization in colonocytes of the rat. Biochem J 231:713-719.
4. Barnard JA, Warwick G. 1993. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 4:495-501.
5. Blachier F, Selamnia M, Robert V, M'Rabet-Touil H, Duée PH. 1995. Metabolism of L-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cells. Biochim Biophys Acta 1268:255-262.
6. Blachier F, Mariotti F, Huneau JF, Tomé D. 2007. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33:547-562.
7. Boren J, Lee WNP, Bassilian S, Centelles JJ, Lim S, Ahmed S, Boros LG, Cascante M. 2003. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem 278:28395-28402.
8. Cuff M, Dyer J, Jones M, Shirazi-Beechey S. 2005. The human colonic monocarboxylate transporter isoform I: Its potential importance to colonic tissue homeostasis. Gastroenterology 128:676-686.
9. Darcy-Vrillon B, Morel MT, Cherbuy C, Posho L, Blachier F, Meslin JC, Duée PH. 1993. Metabolic characteristics of pig colonocytes after adaptation to a high fiber diet. J Nutr 123:234-243.
10. Davie JR. 2003. Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485S-2493S.
11. De Haan JB, Gevers W, Parker MI. 1986. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res 46:713-716.
12. Di Gennaro E, BruzzeseF, CaragliaM, Abruzzese A, Budillon A. 2004. Acetylation of proteins as novel target for antitumor therapy. Amino Acids 26:435-441.
13. Druesne-Pecollo N, Pagniez A, Thomas M, Cherbuy C, Duée PH, Martel P, Chaumontet C. 2006. Diallyl disulfide increases CDKNIA promoter-associated histone acetylation in human colon tumor cell lines. J Agric Food Chem 54:7503-7507.
14. Flemming SE, Fitch MD, DeVries S, Liu ML, Kight C. 1991. Nutrient utilization by cells isolated from rat jejunum, cecum and colon. J Nutr 121:869-878.
15. Gamet L, Daviaud D, Denis-Pouxviel C, Remezy C, Murat JC. 1992. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT-29. Int J Cancer 52:286-289.
16. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349-352.
17. Heerdt BG, Houston MA, Augenlicht LH. I997. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 8:523-532.
18. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. 2002. The effects ofshort-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132:1012-1017.
19. Kiefer J, Beyer-Sehlmeyer G, Pool-Zobel BL. 2006. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT-29 colon cancer cells. Br J Nutr 96:803-810.
20. Leschelle X, Delpal S, Goubern M, Blottière HM, Blachier F. 2000. Butyrate metabolism upstream and downstream acetylCoA synthesis and growth control of human colon carcinoma cells. Eur J Biochem 267:6435-6442.
21. Leschelle X, Goubern M, Andriamihaja M, Blottière HM, Couplan E, Gonzales-Barroso M, Petit C, Pagniez A, Chaumontet C, Mignotte B, Bouillaud F, Blachier F. 2005. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim Biophys Acta 1725:201-212.
22. Macfarlane GT, Cummings JH. 1991. The colonic flora, fermentation and large bowel digestive function In: Philipps SF, Pemberton JH, Shorter RG, editors. The large intestine: Physiology, pathophysiology and disease. New York: Raven Press. pp 51-92.
23. Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, Gibson PR. 2001. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120:889-899.
24. Mayeur C, Veuillet G, Michaud M, Raul F, Blottière HM, Blachier F. 2005. Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle. Biochim Biophys Acta 1745:111-123.
25. Mortensen PB, Clausen MR. 1996. The degradation of amino acids, proteins and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 98:353-360.
26. Mouillé B, Robert V, Blachier F. 2004. Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion. Am J Physiol 287:G344-G351.
27. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, TokinoT, Yamagishi H, Oka T, Nomura H, Sakai T. 1997. Butyrate activates the WAFI/Cipl gene promoter through Spl sites in a p53-negative human colon cancer cell line. J Biol Chem 272:22199-22206.
28. Rechkemmer G, Ronnan K, Engelhardt W. 1988. Fermentation of polysaccharides and absorption of short-chain fatty acids in the mammalian hindgut. Comp Biochem Physiol 90A:563-568.
29. Roediger WE. 1982. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83:424-429.
30. Roediger WEW, Kapaniris O, Millard S. 1992. Lipogenesis from n-butyrate in colonocytes. Action of reducing agents and 5-aminosalicylic acid with relevance to ulcerative colitis. Mol Cell Biochem 118:113-118.
31. Sait Inan M, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. 2000. The luminal short-chain fatty acid butyrate modulates NF-KB activity in a human colonic epithelial cell line. Gastroenterology 118:724-734.
32. Sealy L, Chalkey R. 1978. The effect of sodium butyrate on histone modification. Cell 14:115-121.
33. Selamnia M, Robert V, Mayeur C, Delpal S, Blachier F. 1998. Denovo synthesis of arginine and ornithine from citrulline in human colon carcinoma cells: Metabolic fate of L-ornithine. Biochim Biophys Acta 1425:93-102.
34. Selamnia M, Robert V, Mayeur C, Duée PH, Blachier F. 1998. Effects of L-valine on growth and polyamine metabolism in human colon carcinoma cells. Biochim Biophys Acta 1379:151-160.
35. Sener A, Blachier F, Rasschaert J, Mourtada A, Malaisse-Lagae F, Malaisse WJ. I989. Stimulus- secretion coupling of arginine-induced insulin release: Comparison with lysine-induced insulin secretion. Endocrinology 124:2558-2567.
36. Siavoshian S, Blottiere H, Cherbut C, Galmiche JP. 1997. Butyrate stimulates cyclin D1 and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun 232:169-172.
37. Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, Blottiere HM. 2000. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: Induction of cyclin D3 and p21 expression. Gut 46:507-514.
38. Smith JG, YokoyamaWH, German JB. 1998. Butyric acid from the diet:Actions at the level of gene expression. Crit Rev Food Sci Nutr 8:259-297.
39. Stryer L. 1988. Fattyacid metabolism. In: Stryer L, editor. Biochemistry. New York: Freeman and Company. pp 469-493.
40. Wang J, Friedman EA. 1998. Shortchain fattyacids induce cell cycle inhibitors in colonocytes. Gastroenterology 114:940-946.
41. Whitehead RH,Young GP, Bhathal PS. 1986. Effects of short chain fattyacids on a new human colon carcinoma cell line (LIM 1215). Gut 27:1457-1463.
42. Yoshida M, Kijima M, Akita M, Beppu T. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265:17174-17179.
43. Zambell L, Fitch MD, Fleming SE. 2003. Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr 133:3509-3515.
44. Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL, Rousset M. 1985. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122:22-29.